Cargando…

Development and early qualitative evidence of two novel patient-reported outcome instruments to assess daily functioning in people with early-stage Parkinson’s

BACKGROUND: Previous research on concepts that are important to people living with early-stage Parkinson’s indicated that ‘functional’ slowness, fine motor skills, and subtle gait abnormalities are cardinal concepts that are not comprehensively captured by existing patient-reported outcome (PRO) ins...

Descripción completa

Detalles Bibliográficos
Autores principales: Morel, Thomas, Cleanthous, Sophie, Andrejack, John, Barker, Roger A., Biagioni, Milton, Blavat, Geraldine, Bloem, Bastiaan R., Boroojerdi, Babak, Brooks, William, Burns, Paul, Cano, Stefan, Gallagher, Casey, Gosden, Lesley, Siu, Carroll, Slagle, Ashley F., Ratcliffe, Natasha, Schroeder, Karlin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10119343/
https://www.ncbi.nlm.nih.gov/pubmed/37079119
http://dx.doi.org/10.1186/s41687-023-00577-9
_version_ 1785029002426056704
author Morel, Thomas
Cleanthous, Sophie
Andrejack, John
Barker, Roger A.
Biagioni, Milton
Blavat, Geraldine
Bloem, Bastiaan R.
Boroojerdi, Babak
Brooks, William
Burns, Paul
Cano, Stefan
Gallagher, Casey
Gosden, Lesley
Siu, Carroll
Slagle, Ashley F.
Ratcliffe, Natasha
Schroeder, Karlin
author_facet Morel, Thomas
Cleanthous, Sophie
Andrejack, John
Barker, Roger A.
Biagioni, Milton
Blavat, Geraldine
Bloem, Bastiaan R.
Boroojerdi, Babak
Brooks, William
Burns, Paul
Cano, Stefan
Gallagher, Casey
Gosden, Lesley
Siu, Carroll
Slagle, Ashley F.
Ratcliffe, Natasha
Schroeder, Karlin
author_sort Morel, Thomas
collection PubMed
description BACKGROUND: Previous research on concepts that are important to people living with early-stage Parkinson’s indicated that ‘functional’ slowness, fine motor skills, and subtle gait abnormalities are cardinal concepts that are not comprehensively captured by existing patient-reported outcome (PRO) instruments that are used in clinical practice and research to assess symptoms and daily functioning within this patient population. We sought to develop novel PRO instruments to address this unmet need. METHODS: PRO instrument development was led by a multidisciplinary research group, including people living with Parkinson’s (termed ‘patient experts’), as well as patient engagement and involvement, regulatory science, clinical, and outcome measurement experts. A first set of PRO instruments, termed Early Parkinson’s Function Slowness (42 items) and Early Parkinson’s Mobility (26 items), were drafted to capture ‘functional’ slowness, fine motor skills, and subtle gait abnormalities. These PRO instruments were used in cognitive debriefing interviews with people living with early-stage Parkinson’s (who were not involved with the multidisciplinary research group) to identify issues with relevance, clarity, ease of completion, conceptual overlap, or missing concepts. RESULTS: Sixty people living with early-stage Parkinson’s were interviewed, which led to refining the items to 45 for the Early Parkinson’s Functional Slowness and 23 for the Early Parkinson’s Mobility PRO instruments. Refinement included rewording items to address clarity issues, merging or splitting items to address overlap issues, and adding new items to address missing concepts. The Early Parkinson’s Function Slowness PRO instrument resulted in a multidimensional instrument covering upper limb, complex/whole body, general activity, and cognitive functional slowness. The Early Parkinson’s Mobility PRO instrument resulted in comprehensive coverage of everyday mobility tasks, with a focus on gait concepts, plus complex/whole body, balance, and lower limb mobility. CONCLUSIONS: The Early Parkinson’s Function Slowness and Early Parkinson’s Mobility PRO instruments aim to address gaps in existing PRO instruments to measure meaningful symptoms and daily functioning in people living with early-stage Parkinson’s. Utilizing a meticulous study design led by a multidisciplinary research group that included patient experts helped to ensure that the PRO instruments were patient-centric, content valid, and meaningful from a clinical and measurement perspective. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s41687-023-00577-9.
format Online
Article
Text
id pubmed-10119343
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-101193432023-04-22 Development and early qualitative evidence of two novel patient-reported outcome instruments to assess daily functioning in people with early-stage Parkinson’s Morel, Thomas Cleanthous, Sophie Andrejack, John Barker, Roger A. Biagioni, Milton Blavat, Geraldine Bloem, Bastiaan R. Boroojerdi, Babak Brooks, William Burns, Paul Cano, Stefan Gallagher, Casey Gosden, Lesley Siu, Carroll Slagle, Ashley F. Ratcliffe, Natasha Schroeder, Karlin J Patient Rep Outcomes Research BACKGROUND: Previous research on concepts that are important to people living with early-stage Parkinson’s indicated that ‘functional’ slowness, fine motor skills, and subtle gait abnormalities are cardinal concepts that are not comprehensively captured by existing patient-reported outcome (PRO) instruments that are used in clinical practice and research to assess symptoms and daily functioning within this patient population. We sought to develop novel PRO instruments to address this unmet need. METHODS: PRO instrument development was led by a multidisciplinary research group, including people living with Parkinson’s (termed ‘patient experts’), as well as patient engagement and involvement, regulatory science, clinical, and outcome measurement experts. A first set of PRO instruments, termed Early Parkinson’s Function Slowness (42 items) and Early Parkinson’s Mobility (26 items), were drafted to capture ‘functional’ slowness, fine motor skills, and subtle gait abnormalities. These PRO instruments were used in cognitive debriefing interviews with people living with early-stage Parkinson’s (who were not involved with the multidisciplinary research group) to identify issues with relevance, clarity, ease of completion, conceptual overlap, or missing concepts. RESULTS: Sixty people living with early-stage Parkinson’s were interviewed, which led to refining the items to 45 for the Early Parkinson’s Functional Slowness and 23 for the Early Parkinson’s Mobility PRO instruments. Refinement included rewording items to address clarity issues, merging or splitting items to address overlap issues, and adding new items to address missing concepts. The Early Parkinson’s Function Slowness PRO instrument resulted in a multidimensional instrument covering upper limb, complex/whole body, general activity, and cognitive functional slowness. The Early Parkinson’s Mobility PRO instrument resulted in comprehensive coverage of everyday mobility tasks, with a focus on gait concepts, plus complex/whole body, balance, and lower limb mobility. CONCLUSIONS: The Early Parkinson’s Function Slowness and Early Parkinson’s Mobility PRO instruments aim to address gaps in existing PRO instruments to measure meaningful symptoms and daily functioning in people living with early-stage Parkinson’s. Utilizing a meticulous study design led by a multidisciplinary research group that included patient experts helped to ensure that the PRO instruments were patient-centric, content valid, and meaningful from a clinical and measurement perspective. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s41687-023-00577-9. Springer International Publishing 2023-04-20 /pmc/articles/PMC10119343/ /pubmed/37079119 http://dx.doi.org/10.1186/s41687-023-00577-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research
Morel, Thomas
Cleanthous, Sophie
Andrejack, John
Barker, Roger A.
Biagioni, Milton
Blavat, Geraldine
Bloem, Bastiaan R.
Boroojerdi, Babak
Brooks, William
Burns, Paul
Cano, Stefan
Gallagher, Casey
Gosden, Lesley
Siu, Carroll
Slagle, Ashley F.
Ratcliffe, Natasha
Schroeder, Karlin
Development and early qualitative evidence of two novel patient-reported outcome instruments to assess daily functioning in people with early-stage Parkinson’s
title Development and early qualitative evidence of two novel patient-reported outcome instruments to assess daily functioning in people with early-stage Parkinson’s
title_full Development and early qualitative evidence of two novel patient-reported outcome instruments to assess daily functioning in people with early-stage Parkinson’s
title_fullStr Development and early qualitative evidence of two novel patient-reported outcome instruments to assess daily functioning in people with early-stage Parkinson’s
title_full_unstemmed Development and early qualitative evidence of two novel patient-reported outcome instruments to assess daily functioning in people with early-stage Parkinson’s
title_short Development and early qualitative evidence of two novel patient-reported outcome instruments to assess daily functioning in people with early-stage Parkinson’s
title_sort development and early qualitative evidence of two novel patient-reported outcome instruments to assess daily functioning in people with early-stage parkinson’s
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10119343/
https://www.ncbi.nlm.nih.gov/pubmed/37079119
http://dx.doi.org/10.1186/s41687-023-00577-9
work_keys_str_mv AT morelthomas developmentandearlyqualitativeevidenceoftwonovelpatientreportedoutcomeinstrumentstoassessdailyfunctioninginpeoplewithearlystageparkinsons
AT cleanthoussophie developmentandearlyqualitativeevidenceoftwonovelpatientreportedoutcomeinstrumentstoassessdailyfunctioninginpeoplewithearlystageparkinsons
AT andrejackjohn developmentandearlyqualitativeevidenceoftwonovelpatientreportedoutcomeinstrumentstoassessdailyfunctioninginpeoplewithearlystageparkinsons
AT barkerrogera developmentandearlyqualitativeevidenceoftwonovelpatientreportedoutcomeinstrumentstoassessdailyfunctioninginpeoplewithearlystageparkinsons
AT biagionimilton developmentandearlyqualitativeevidenceoftwonovelpatientreportedoutcomeinstrumentstoassessdailyfunctioninginpeoplewithearlystageparkinsons
AT blavatgeraldine developmentandearlyqualitativeevidenceoftwonovelpatientreportedoutcomeinstrumentstoassessdailyfunctioninginpeoplewithearlystageparkinsons
AT bloembastiaanr developmentandearlyqualitativeevidenceoftwonovelpatientreportedoutcomeinstrumentstoassessdailyfunctioninginpeoplewithearlystageparkinsons
AT boroojerdibabak developmentandearlyqualitativeevidenceoftwonovelpatientreportedoutcomeinstrumentstoassessdailyfunctioninginpeoplewithearlystageparkinsons
AT brookswilliam developmentandearlyqualitativeevidenceoftwonovelpatientreportedoutcomeinstrumentstoassessdailyfunctioninginpeoplewithearlystageparkinsons
AT burnspaul developmentandearlyqualitativeevidenceoftwonovelpatientreportedoutcomeinstrumentstoassessdailyfunctioninginpeoplewithearlystageparkinsons
AT canostefan developmentandearlyqualitativeevidenceoftwonovelpatientreportedoutcomeinstrumentstoassessdailyfunctioninginpeoplewithearlystageparkinsons
AT gallaghercasey developmentandearlyqualitativeevidenceoftwonovelpatientreportedoutcomeinstrumentstoassessdailyfunctioninginpeoplewithearlystageparkinsons
AT gosdenlesley developmentandearlyqualitativeevidenceoftwonovelpatientreportedoutcomeinstrumentstoassessdailyfunctioninginpeoplewithearlystageparkinsons
AT siucarroll developmentandearlyqualitativeevidenceoftwonovelpatientreportedoutcomeinstrumentstoassessdailyfunctioninginpeoplewithearlystageparkinsons
AT slagleashleyf developmentandearlyqualitativeevidenceoftwonovelpatientreportedoutcomeinstrumentstoassessdailyfunctioninginpeoplewithearlystageparkinsons
AT ratcliffenatasha developmentandearlyqualitativeevidenceoftwonovelpatientreportedoutcomeinstrumentstoassessdailyfunctioninginpeoplewithearlystageparkinsons
AT schroederkarlin developmentandearlyqualitativeevidenceoftwonovelpatientreportedoutcomeinstrumentstoassessdailyfunctioninginpeoplewithearlystageparkinsons